NCT04029935

Brief Summary

The main objective of this project is: 1\. To assess the influence of physical fatigue on a return-to-play test battery in a healthy population. In a later stage, these experiments could be carried out in a clinical context (e.g. in an ankle sprain population). The researchers will use a randomized, placebo controlled, counter-balanced, cross-over design. Twenty healthy subjects will visit the lab 3 times. On the first visit (familiarisation trial), the investigators will collect the participants' characteristics. The participants will also be familiarized to the procedures and materials of the experiment during this first visit. The second and third visit contain the experimental setup and will proceed as follows: first, the participants will fill in a pre-test checklist, a mental fatigue scale (M-VAS) and motivation scale. In the mean time a little blood will be collected from the ear lobe to determine lactate and glucose levels; also, blood pressure will be checked. Next, the subjects will carry out a functional test battery (hop test, vertical jump test, Y-balance test, and a balance reaction-time test). Session rate of perceived exertion (SRPE) is measured to indicate how fatigued the participants feel due to the test battery; also, M-VAS is collected once more, as well blood lactate, glucose and blood pressure. These measures are followed by either a physical fatigue inducing task (Modified 30 seconds Wingate protocol) or time-matched control task (sitting on the bike without pedalling). Afterwards, researchers will collect blood lactate, glucose and blood pressure two times more; participants have to fill in M-VAS (2x), perform the same test battery, and fill in the SRPE scale one more time. Heart frequency will be measured continuously during the trials.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

July 19, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 23, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2020

Completed
Last Updated

February 6, 2020

Status Verified

February 1, 2020

Enrollment Period

7 months

First QC Date

July 18, 2019

Last Update Submit

February 5, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Single-leg hop test

    Single-leg hop test for distance performance

    Change in single-leg hop test for distance performance: from baseline and 20 minutes after baseline (immediately after the assigned interventions)

  • Vertical jump test

    Vertical jump height performance

    Change in vertical jump height performance: from baseline and 20 minutes after baseline (immediately after the assigned interventions)

  • Y-balance test

    Balance and reach performance; participants have to maintain their balance while reaching as far as possible along 3 different directions.

    Change in Y-balance performance: from baseline and 20 minutes after baseline (immediately after the assigned interventions)

  • Balance-reaction time test

    Balance and reaction time performance; participants have to maintain their balance while reacting as fast as possible in 3 different directions.

    Change in balance and reaction time performance: from baseline and 20 minutes after baseline (immediately after the assigned interventions)

Secondary Outcomes (6)

  • Mental fatigue Visual Analogue Scale (M-VAS)

    Change in M-VAS: at baseline, 10 min after baseline (immediately after the first test battery), 15 min after baseline (immediately after the assigned interventions) and 25 min after baseline (immediately after the final test battery)

  • Perception of effort (Session RPE)

    Change in session RPE: at baseline (immediately after the first test battery), 15 min after baseline (immediately after the final test battery)

  • Self-reported motivation

    At baseline: prior to the first test battery

  • Blood lactate

    Change in blood lactate: at baseline, 10 min after baseline (immediately after the first test battery), 15 min after baseline (immediately after the assigned interventions) and 25 min after baseline (immediately after the final test battery)

  • Blood glucose

    Change in blood glucose: at baseline, 10 min after baseline (immediately after the first test battery), 15 min after baseline (immediately after the assigned interventions) and 25 min after baseline (immediately after the final test battery)

  • +1 more secondary outcomes

Study Arms (2)

Physical Fatigue Condition

EXPERIMENTAL
Behavioral: Physical Fatigue

Control Condition

PLACEBO COMPARATOR
Behavioral: Control

Interventions

Maximal cycling effort for 30s (Wingate modified)

Physical Fatigue Condition
ControlBEHAVIORAL

time-matched task (sitting on the bike without pedalling)

Control Condition

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy (No neurological/cardiorespiratory/psychological/musculoskeletal disorders)
  • Male and female
  • No medication
  • Non-smoker
  • Between 18 and 35 years old

You may not qualify if:

  • Back and/or lower extremity injuries during the past 6 months
  • Bone/joint abnormalities
  • Dizziness, history of loss of consciousness, any inner ear disorders
  • Nervous system disorders or dysfunctions
  • Uncorrected eye disorders/dysfunctions
  • Illness
  • Use of medication or any kind of drugs
  • Use of alcohol, caffeine and heavy efforts 24 hours before each trial
  • Not eating the same meal the night before and the morning of each experimental trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vrije Universiteit Brussel

Brussels, 1050, Belgium

Location

Study Officials

  • Romain Meeusen, Professor

    Vrije Universiteit Brussel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Dr.

Study Record Dates

First Submitted

July 18, 2019

First Posted

July 23, 2019

Study Start

July 19, 2019

Primary Completion

February 3, 2020

Study Completion

February 3, 2020

Last Updated

February 6, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations